Literature DB >> 27662091

Editing DNA Methylation in the Mammalian Genome.

X Shawn Liu1, Hao Wu1, Xiong Ji1, Yonatan Stelzer1, Xuebing Wu1, Szymon Czauderna2, Jian Shu1, Daniel Dadon3, Richard A Young3, Rudolf Jaenisch4.   

Abstract

Mammalian DNA methylation is a critical epigenetic mechanism orchestrating gene expression networks in many biological processes. However, investigation of the functions of specific methylation events remains challenging. Here, we demonstrate that fusion of Tet1 or Dnmt3a with a catalytically inactive Cas9 (dCas9) enables targeted DNA methylation editing. Targeting of the dCas9-Tet1 or -Dnmt3a fusion protein to methylated or unmethylated promoter sequences caused activation or silencing, respectively, of an endogenous reporter. Targeted demethylation of the BDNF promoter IV or the MyoD distal enhancer by dCas9-Tet1 induced BDNF expression in post-mitotic neurons or activated MyoD facilitating reprogramming of fibroblasts into myoblasts, respectively. Targeted de novo methylation of a CTCF loop anchor site by dCas9-Dnmt3a blocked CTCF binding and interfered with DNA looping, causing altered gene expression in the neighboring loop. Finally, we show that these tools can edit DNA methylation in mice, demonstrating their wide utility for functional studies of epigenetic regulation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27662091      PMCID: PMC5062609          DOI: 10.1016/j.cell.2016.08.056

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  56 in total

1.  CTCF establishes discrete functional chromatin domains at the Hox clusters during differentiation.

Authors:  Varun Narendra; Pedro P Rocha; Disi An; Ramya Raviram; Jane A Skok; Esteban O Mazzoni; Danny Reinberg
Journal:  Science       Date:  2015-02-27       Impact factor: 47.728

Review 2.  DNA methylation and human disease.

Authors:  Keith D Robertson
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

3.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.

Authors:  Xuebing Wu; David A Scott; Andrea J Kriz; Anthony C Chiu; Patrick D Hsu; Daniel B Dadon; Albert W Cheng; Alexandro E Trevino; Silvana Konermann; Sidi Chen; Rudolf Jaenisch; Feng Zhang; Phillip A Sharp
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

Review 4.  The 3D genome in transcriptional regulation and pluripotency.

Authors:  David U Gorkin; Danny Leung; Bing Ren
Journal:  Cell Stem Cell       Date:  2014-06-05       Impact factor: 24.633

5.  TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts.

Authors:  Diana L Bernstein; John E Le Lay; Elena G Ruano; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

6.  3D Chromosome Regulatory Landscape of Human Pluripotent Cells.

Authors:  Xiong Ji; Daniel B Dadon; Benjamin E Powell; Zi Peng Fan; Diego Borges-Rivera; Sigal Shachar; Abraham S Weintraub; Denes Hnisz; Gianluca Pegoraro; Tong Ihn Lee; Tom Misteli; Rudolf Jaenisch; Richard A Young
Journal:  Cell Stem Cell       Date:  2015-12-10       Impact factor: 24.633

7.  Global epigenomic reconfiguration during mammalian brain development.

Authors:  Ryan Lister; Eran A Mukamel; Joseph R Nery; Mark Urich; Clare A Puddifoot; Nicholas D Johnson; Jacinta Lucero; Yun Huang; Andrew J Dwork; Matthew D Schultz; Miao Yu; Julian Tonti-Filippini; Holger Heyn; Shijun Hu; Joseph C Wu; Anjana Rao; Manel Esteller; Chuan He; Fatemeh G Haghighi; Terrence J Sejnowski; M Margarita Behrens; Joseph R Ecker
Journal:  Science       Date:  2013-07-04       Impact factor: 47.728

8.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

Authors:  Wei Xu; Hui Yang; Ying Liu; Ying Yang; Ping Wang; Se-Hee Kim; Shinsuke Ito; Chen Yang; Pu Wang; Meng-Tao Xiao; Li-xia Liu; Wen-qing Jiang; Jing Liu; Jin-ye Zhang; Bin Wang; Stephen Frye; Yi Zhang; Yan-hui Xu; Qun-ying Lei; Kun-Liang Guan; Shi-min Zhao; Yue Xiong
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 38.585

9.  CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.

Authors:  Samrat Roy Choudhury; Yi Cui; Katarzyna Lubecka; Barbara Stefanska; Joseph Irudayaraj
Journal:  Oncotarget       Date:  2016-07-19

10.  Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system.

Authors:  Baohui Chen; Luke A Gilbert; Beth A Cimini; Joerg Schnitzbauer; Wei Zhang; Gene-Wei Li; Jason Park; Elizabeth H Blackburn; Jonathan S Weissman; Lei S Qi; Bo Huang
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

View more
  373 in total

Review 1.  Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.

Authors:  Marliette R Matos; Seok-Man Ho; Nadine Schrode; Kristen J Brennand
Journal:  Mol Cell Neurosci       Date:  2020-07-23       Impact factor: 4.314

2.  Genome, Epigenome, and Transcriptome Editing via Chemical Modification of Nucleobases in Living Cells.

Authors:  Brodie L Ranzau; Alexis C Komor
Journal:  Biochemistry       Date:  2018-12-12       Impact factor: 3.162

Review 3.  Somatic Cell Nuclear Transfer Reprogramming: Mechanisms and Applications.

Authors:  Shogo Matoba; Yi Zhang
Journal:  Cell Stem Cell       Date:  2018-07-19       Impact factor: 24.633

Review 4.  Cancer induction and suppression with transcriptional control and epigenome editing technologies.

Authors:  Shota Nakade; Takashi Yamamoto; Tetsushi Sakuma
Journal:  J Hum Genet       Date:  2017-11-14       Impact factor: 3.172

Review 5.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

6.  Dissecting the Functional Consequences of De Novo DNA Methylation Dynamics in Human Motor Neuron Differentiation and Physiology.

Authors:  Michael J Ziller; Juan A Ortega; Katharina A Quinlan; David P Santos; Hongcang Gu; Eric J Martin; Christina Galonska; Ramona Pop; Susanne Maidl; Alba Di Pardo; Mei Huang; Herbert Y Meltzer; Andreas Gnirke; C J Heckman; Alexander Meissner; Evangelos Kiskinis
Journal:  Cell Stem Cell       Date:  2018-03-15       Impact factor: 24.633

7.  The Effects of Voluntary Physical Exercise-Activated Neurotrophic Signaling in Rat Hippocampus on mRNA Levels of Downstream Signaling Molecules.

Authors:  Christina A E Solvsten; Tina F Daugaard; Yonglun Luo; Frank de Paoli; Jane H Christensen; Anders L Nielsen
Journal:  J Mol Neurosci       Date:  2017-04-24       Impact factor: 3.444

8.  Role of DNA De Novo (De)Methylation in the Kidney in Salt-Induced Hypertension.

Authors:  Pengyuan Liu; Yong Liu; Han Liu; Xiaoqing Pan; Yingchuan Li; Kristie Usa; Manoj K Mishra; Jing Nie; Mingyu Liang
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 9.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

Review 10.  In vivo epigenome editing and transcriptional modulation using CRISPR technology.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  Transgenic Res       Date:  2018-10-04       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.